BCN HEALTH publishes a study evaluating the costs due to productivity losses associated to gastric cancer in Spain
In economic terms, gastric cancer deaths accounted for costs of €1,239.34 million in 2013, rising to €1,242.04 million by 2021, for a total of €11,469.07 million over the study period.

BCN HEALTH has published the study ‘Gastric cancer in Spain: evaluating productivity loss and economic impact’ in the Journal of Medical Economics, an international journal publishing rigorously peer-reviewed review articles and original papers in the pharmacoeconomics and healthcare research community.
BCN HEALTH conducted an analysis of the productivity losses associated to premature mortality from gastric cancer in Spain between 2013 and 2022. This analysis was based in the human capital approach, which estimates the indirect costs that the disease represents for the individual, family, society or employer via the calculation of the income and productivity of an individual that are prevented when premature death occurs. To this end, statistics on mortality and salaries were extracted from the Spanish National Statistics Institute (INE). The costs of premature mortality were estimated using age- and sex-specific annual wages from death age to age of retirement.
Gastric cancer caused 51,814 deaths over the study period with a slight annual decline, predominantly affecting men. Approximately 23% of deaths occurred among people of working age, amounting to a total of 122,632 years of potential life lost. In economic terms, gastric cancer deaths accounted for costs of €1,239.34 million in 2013, rising to €1,242.04 million by 2021, for a total of €11,469.07 million over the study period. These findings underline the significant health and economic challenges posed by gastric cancer, highlighting the need for targeted interventions to mitigate its impact on both individuals and healthcare systems.
More information can be found at https://doi.org/10.1080/13696998.2024.2412946